Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Neoplastic Stem Cells"" wg kryterium: Temat


Tytuł:
Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets.
Autorzy:
Jhanwar-Uniyal M; Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, NY 10595, USA.
Zeller SL; Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, NY 10595, USA.
Spirollari E; Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, NY 10595, USA.
Das M; Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, NY 10595, USA.
Hanft SJ; Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, NY 10595, USA.
Gandhi CD; Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, NY 10595, USA.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Feb 27; Vol. 13 (5). Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Glioblastoma*/metabolism
Sirolimus*/pharmacology
Neoplastic Stem Cells*/metabolism
Humans ; Intercellular Signaling Peptides and Proteins/therapeutic use ; Mechanistic Target of Rapamycin Complex 1/metabolism ; Mechanistic Target of Rapamycin Complex 2/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction ; TOR Serine-Threonine Kinases/metabolism
Czasopismo naukowe
Tytuł:
Revealing role of epigenetic modifiers and DNA oxidation in cell-autonomous regulation of Cancer stem cells.
Autorzy:
Ferrer-Diaz AI; Department of Medicine - Division of Hematology/Oncology, Rutgers, New Jersey Medical School, Newark, NJ, 07103, USA.; Rutgers School of Graduate Studies at New Jersey Medical School, Newark, NJ, USA.
Sinha G; Department of Medicine - Division of Hematology/Oncology, Rutgers, New Jersey Medical School, Newark, NJ, 07103, USA.; Rutgers School of Graduate Studies at New Jersey Medical School, Newark, NJ, USA.
Petryna A; Department of Medicine - Division of Hematology/Oncology, Rutgers, New Jersey Medical School, Newark, NJ, 07103, USA.; Rutgers School of Graduate Studies at New Jersey Medical School, Newark, NJ, USA.
Gonzalez-Bermejo R; University of Puerto Rico, Cayey, PR, Puerto Rico.
Kenfack Y; Department of Medicine - Division of Hematology/Oncology, Rutgers, New Jersey Medical School, Newark, NJ, 07103, USA.; Rutgers School of Graduate Studies at New Jersey Medical School, Newark, NJ, USA.
Adetayo O; Rutgers School of Dental Medicine, Newark, NJ, USA.
Patel SA; Division of Hematology and Oncology, Department of Medicine, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, MA, USA.
Hooda-Nehra A; Department of Medicine - Division of Hematology/Oncology, Rutgers, New Jersey Medical School, Newark, NJ, 07103, USA.; Rutgers Cancer Institute of New Jersey, Newark, NJ, USA.
Rameshwar P; Department of Medicine - Division of Hematology/Oncology, Rutgers, New Jersey Medical School, Newark, NJ, 07103, USA. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2024 Feb 12; Vol. 22 (1), pp. 119. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplastic Stem Cells*/pathology
Neoplasms*/pathology
Humans ; Histones/genetics ; Epigenesis, Genetic ; Methyltransferases/genetics ; DNA ; Intracellular Signaling Peptides and Proteins/genetics
Czasopismo naukowe
Tytuł:
METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation.
Autorzy:
Xue M; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.; Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Dong L; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.; Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX, 7539, USA.
Zhang H; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Li Y; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.; Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China.
Qiu K; Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA.
Zhao Z; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
Gao M; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Han L; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.; School of Pharmacy, China Medical University, Shenyang, 110001, Liaoning, China.
Chan AKN; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Li W; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Leung K; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Wang K; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Pokharel SP; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Qing Y; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Liu W; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Wang X; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Ren L; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Bi H; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Yang L; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Shen C; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Chen Z; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Melstrom L; Division of Surgical Oncology, Department of Surgery, Beckman Research Institute of City of Hope Comprehensive Cancer Center, Duarte, CA, 91010, USA.
Li H; Department of Molecular Medicine, City of Hope National Medical Center, Duarte, CA, 91016, USA.
Timchenko N; Division of General and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Deng X; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Huang W; Department of Diabetes Complications and Metabolism, Diabetes and Metabolism Research Institute, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.; Graduate School of Biological Science, City of Hope, Duarte, CA, 91010, USA.
Rosen ST; City of Hope Comprehensive Cancer Center, City of Hope, Duarte, CA, 91010, USA.
Tian J; State Key Laboratory of Medical Genomics, Clinical Trial Center, Shanghai Institute of Endocrine and Metabolic Diseases, Department of Endocrinology and Metabolism, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Xu L; Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX, 7539, USA.
Diao J; Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA.
Chen CW; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.; City of Hope Comprehensive Cancer Center, City of Hope, Duarte, CA, 91010, USA.
Chen J; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.; City of Hope Comprehensive Cancer Center, City of Hope, Duarte, CA, 91010, USA.; Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, 91010, USA.
Shen B; Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .
Chen H; Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .
Su R; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA. .; City of Hope Comprehensive Cancer Center, City of Hope, Duarte, CA, 91010, USA. .
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2024 Feb 01; Vol. 17 (1), pp. 7. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
Neoplastic Stem Cells*/pathology
Animals ; Humans ; Mice ; Cell Line, Tumor ; Cell Self Renewal/genetics ; Methyltransferases/genetics ; Methyltransferases/metabolism ; Protein Biosynthesis ; Ribosomes/metabolism ; RNA
Czasopismo naukowe
Tytuł:
SOX2 Expression Does Not Guarantee Cancer Stem Cell-like Characteristics in Lung Adenocarcinoma.
Autorzy:
Bae SH; Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Republic of Korea.
Lee KY; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Republic of Korea.; Division of Cancer Biology, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.
Han S; Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.
Yun CW; Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.
Park C; Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Republic of Korea.
Jang H; Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Republic of Korea.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Jan 24; Vol. 13 (3). Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Neoplastic Stem Cells*/pathology
SOXB1 Transcription Factors*/genetics
SOXB1 Transcription Factors*/metabolism
Humans ; RNA, Small Interfering/metabolism
Czasopismo naukowe
Tytuł:
A positive feedback between PDIA3P1 and OCT4 promotes the cancer stem cell properties of esophageal squamous cell carcinoma.
Autorzy:
Huang T; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
You Q; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Huang D; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Zhang Y; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
He Z; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Shen X; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Li F; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Shen Q; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Onyebuchi IC; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Wu C; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Liu F; Department of Thoracic Surgery, Lishui Branch, Zhongda Hospital Affiliated to Southeast University, Nanjing, 211200, China. .
Zhu S; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2024 Jan 22; Vol. 22 (1), pp. 60. Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Esophageal Neoplasms*/genetics
Esophageal Squamous Cell Carcinoma*/genetics
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Octamer Transcription Factor-3*/genetics
Octamer Transcription Factor-3*/metabolism
Neoplastic Stem Cells*/metabolism
Humans ; RNA ; Ubiquitin-Protein Ligases ; Receptors, Nerve Growth Factor
Czasopismo naukowe
Tytuł:
Downregulation of TAB182 promotes cancer stem-like cell properties and therapeutic resistance in triple-negative breast cancer cells.
Autorzy:
He H; Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.; NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, 130021, People's Republic of China.
Wang S; Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.
Zhang W; Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.
Gao S; Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.
Guan H; Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China. .
Zhou P; Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Nov 13; Vol. 23 (1), pp. 1101. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplastic Stem Cells*/metabolism
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/metabolism
Telomeric Repeat Binding Protein 1*/genetics
Humans ; Cell Line, Tumor ; Cell Proliferation ; Down-Regulation ; Drug Resistance, Neoplasm/genetics ; Gene Expression Regulation, Neoplastic ; Signal Transduction
Czasopismo naukowe
Tytuł:
Cancer Stem Cells and Androgen Receptor Signaling: Partners in Disease Progression.
Autorzy:
Quintero JC; Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 11000, Mexico.
Díaz NF; Departamento de Fisiología y Desarrollo Celular, Instituto Nacional de Perinatología, Mexico City 11000, Mexico.
Rodríguez-Dorantes M; Laboratorio de Oncogenómica, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.
Camacho-Arroyo I; Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 11000, Mexico.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 11; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplastic Stem Cells*/metabolism
Prostatic Neoplasms*/metabolism
Receptors, Androgen*/metabolism
Humans ; Male ; Cell Line, Tumor ; Disease Progression ; Signal Transduction
Czasopismo naukowe
Tytuł:
Downregulation of circ-Foxo3 in breast cancer stem-like cells.
Autorzy:
Kamalabadi-Farahani M; Department of Tissue Engineering, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran. .
Atashi A; Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Shahroud University of Medical Sciences, Shahroud, Iran.
Eslami MM; Department of Hematology, School of Medicine, Tarbiat Modares University (TMU), Tehran, Iran.
Pokaż więcej
Źródło:
BMC research notes [BMC Res Notes] 2023 Jul 03; Vol. 16 (1), pp. 132. Date of Electronic Publication: 2023 Jul 03.
Typ publikacji:
Journal Article
MeSH Terms:
RNA, Circular*/genetics
Breast Neoplasms*/genetics
Neoplastic Stem Cells*
Forkhead Box Protein O3*/genetics
Spheroids, Cellular ; Gene Expression Regulation, Neoplastic ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Cuproptosis engages in c-Myc-mediated breast cancer stemness.
Autorzy:
Wang R; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China.
Xu K; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China.
Chen Q; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China.
Hu Q; Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, China.
Zhang J; Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center, Shanghai, China. .
Guan X; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China. .; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, 211166, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 Jun 23; Vol. 21 (1), pp. 409. Date of Electronic Publication: 2023 Jun 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Apoptosis*
Proto-Oncogene Proteins c-myc*/genetics
Proto-Oncogene Proteins c-myc*/metabolism
Breast Neoplasms*
Neoplastic Stem Cells*
Copper ; Phenotype ; Humans ; Female
Czasopismo naukowe
Tytuł:
LINC00909 up-regulates pluripotency factors and promotes cancer stemness and metastasis in pancreatic ductal adenocarcinoma by targeting SMAD4.
Autorzy:
Li Z; Department of General Surgery, Heyuan people's Hospital, Heyuan, 517000, China.; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Ma Z; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China.
Wang S; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China.
Yan Q; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; South China University of Technology School of Medicine, Guangzhou, Guangdong Province, 510006, China.
Zhuang H; Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510080, China.
Zhou Z; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; South China University of Technology School of Medicine, Guangzhou, Guangdong Province, 510006, China.
Liu C; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China.
Chen Y; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; South China University of Technology School of Medicine, Guangzhou, Guangdong Province, 510006, China.
Han M; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China.
Wu Z; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China.
Huang S; Department of General Surgery, Heyuan people's Hospital, Heyuan, 517000, China.; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China.; South China University of Technology School of Medicine, Guangzhou, Guangdong Province, 510006, China.
Zhou Q; Department of General Surgery, Hui Ya Hospital of The First Affiliated Hospital, Sun Yat-sen University, Huizhou, Guangdong, 516081, China. .; Department of Liver Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China. .
Hou B; Department of General Surgery, Heyuan people's Hospital, Heyuan, 517000, China. .; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China. .; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China. .; South China University of Technology School of Medicine, Guangzhou, Guangdong Province, 510006, China. .
Zhang C; Department of General Surgery, Heyuan people's Hospital, Heyuan, 517000, China. .; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China. .; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China. .; South China University of Technology School of Medicine, Guangzhou, Guangdong Province, 510006, China. .
Pokaż więcej
Źródło:
Biology direct [Biol Direct] 2024 Mar 19; Vol. 19 (1), pp. 24. Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Pancreatic Ductal*/genetics
Carcinoma, Pancreatic Ductal*/metabolism
Carcinoma, Pancreatic Ductal*/pathology
Pancreatic Neoplasms*/genetics
Animals ; Humans ; Mice ; Carcinogenesis/genetics ; Cell Line, Tumor ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology ; Phenotype ; Smad4 Protein/genetics ; Smad4 Protein/metabolism ; RNA, Untranslated/genetics
Czasopismo naukowe
Tytuł:
Modeling 5-FU-Induced Chemotherapy Selection of a Drug-Resistant Cancer Stem Cell Subpopulation.
Autorzy:
Ramović Hamzagić A; Faculty of Medical Sciences, Department of Genetics, University of Kragujevac, 34000 Kragujevac, Serbia.; Serbia for Harm Reduction of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
Cvetković D; Faculty of Medical Sciences, Department of Genetics, University of Kragujevac, 34000 Kragujevac, Serbia.; Serbia for Harm Reduction of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
Gazdić Janković M; Faculty of Medical Sciences, Department of Genetics, University of Kragujevac, 34000 Kragujevac, Serbia.; Serbia for Harm Reduction of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
Milivojević Dimitrijević N; Institute for Information Technologies Kragujevac, University of Kragujevac, Liceja Kneževine Srbije 1A, 34000 Kragujevac, Serbia.
Nikolić D; Institute for Information Technologies Kragujevac, University of Kragujevac, Liceja Kneževine Srbije 1A, 34000 Kragujevac, Serbia.; Bioengineering Research and Development Center (BioIRC), Prvoslava Stojanovica 6, 34000 Kragujevac, Serbia.
Živanović M; Institute for Information Technologies Kragujevac, University of Kragujevac, Liceja Kneževine Srbije 1A, 34000 Kragujevac, Serbia.
Kastratović N; Faculty of Medical Sciences, Department of Genetics, University of Kragujevac, 34000 Kragujevac, Serbia.; Serbia for Harm Reduction of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
Petrović I; Faculty of Medical Sciences, Department of Pathophysiology, University of Kragujevac, 34000 Kragujevac, Serbia.
Nikolić S; Faculty of Medical Sciences, Department of Genetics, University of Kragujevac, 34000 Kragujevac, Serbia.; Serbia for Harm Reduction of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
Jovanović M; Faculty of Sciences, University of Kragujevac, Radoja Domanovića 12, 34000 Kragujevac, Serbia.
Šeklić D; Institute for Information Technologies Kragujevac, University of Kragujevac, Liceja Kneževine Srbije 1A, 34000 Kragujevac, Serbia.
Filipović N; Bioengineering Research and Development Center (BioIRC), Prvoslava Stojanovica 6, 34000 Kragujevac, Serbia.; Faculty of Engineering, University of Kragujevac, Sestre Janjić 6, 34000 Kragujevac, Serbia.
Ljujić B; Faculty of Medical Sciences, Department of Genetics, University of Kragujevac, 34000 Kragujevac, Serbia.; Serbia for Harm Reduction of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Feb 25; Vol. 31 (3), pp. 1221-1234. Date of Electronic Publication: 2024 Feb 25.
Typ publikacji:
Journal Article
MeSH Terms:
Artificial Intelligence*
Neoplasms*/pathology
Humans ; Cell Line, Tumor ; Aldehyde Dehydrogenase 1 Family ; Fluorouracil/pharmacology ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology
Czasopismo naukowe
Tytuł:
Cyclophilin A Inhibitors Suppress Proliferation and Induce Apoptosis of MKN45 Gastric Cancer Stem-like Cells by Regulating CypA/CD147-Mediated Signaling Pathway.
Autorzy:
Cho HJ; Department of Life Science and Biochemical Engineering, Graduate School, Sun Moon University, Asan 31460, Republic of Korea.
Jung HJ; Department of Life Science and Biochemical Engineering, Graduate School, Sun Moon University, Asan 31460, Republic of Korea.; Department of Pharmaceutical Engineering and Biotechnology, Sun Moon University, Asan 31460, Republic of Korea.; Genome-Based BioIT Convergence Institute, Sun Moon University, Asan 31460, Republic of Korea.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 01; Vol. 24 (5). Date of Electronic Publication: 2023 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Cyclophilin A*/antagonists & inhibitors
Cyclophilin A*/metabolism
Neoplastic Stem Cells*/drug effects
Neoplastic Stem Cells*/metabolism
Stomach Neoplasms*/drug therapy
Antineoplastic Agents*/pharmacology
Basigin*/metabolism
Animals ; Chick Embryo ; Humans ; Apoptosis/drug effects ; Cell Proliferation/drug effects ; Neoplasm Recurrence, Local/drug therapy ; Signal Transduction
Czasopismo naukowe
Tytuł:
Osteogenic and Adipogenic Differentiation Potential of Oral Cancer Stem Cells May Offer New Treatment Modalities.
Autorzy:
Jaksic Karisik M; Department of Human Genetics, School of Dental Medicine, University of Belgrade, Dr. Subotica 8, 11000 Belgrade, Serbia.
Lazarevic M; Department of Human Genetics, School of Dental Medicine, University of Belgrade, Dr. Subotica 8, 11000 Belgrade, Serbia.
Mitic D; Department of Human Genetics, School of Dental Medicine, University of Belgrade, Dr. Subotica 8, 11000 Belgrade, Serbia.
Nikolic N; Department of Human Genetics, School of Dental Medicine, University of Belgrade, Dr. Subotica 8, 11000 Belgrade, Serbia.
Milosevic Markovic M; Department of Human Genetics, School of Dental Medicine, University of Belgrade, Dr. Subotica 8, 11000 Belgrade, Serbia.
Jelovac D; Clinic for Maxillofacial Surgery, School of Dental Medicine, University of Belgrade, Dr. Subotica 8, 11000 Belgrade, Serbia.
Milasin J; Department of Human Genetics, School of Dental Medicine, University of Belgrade, Dr. Subotica 8, 11000 Belgrade, Serbia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Feb 28; Vol. 24 (5). Date of Electronic Publication: 2023 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
MicroRNAs*/metabolism
Mouth Neoplasms*/pathology
Neoplastic Stem Cells*/cytology
Neoplastic Stem Cells*/metabolism
Adipogenesis*
Osteogenesis*
Humans
Czasopismo naukowe
Tytuł:
Hypoxia drives shared and distinct transcriptomic changes in two invasive glioma stem cell lines.
Autorzy:
Marallano VJ; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Ughetta ME; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Tejero R; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Nanda S; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Ramalingam R; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Stalbow L; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Sattiraju A; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Huang Y; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Ramakrishnan A; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Shen L; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Wojcinski A; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA.
Kesari S; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA.
Zou H; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Tsankov AM; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. .
Friedel RH; Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 27; Vol. 14 (1), pp. 7246. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioma*/pathology
Glioblastoma*/pathology
Humans ; Hypoxia/genetics ; Hypoxia/metabolism ; Cell Line, Tumor ; Gene Expression Profiling ; Neoplastic Stem Cells/metabolism ; Cell Hypoxia/genetics
Czasopismo naukowe
Tytuł:
Frizzled class receptor 5 contributes to ovarian cancer chemoresistance through aldehyde dehydrogenase 1A1.
Autorzy:
Xia Y; Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, Liaoning Province, 110122, P.R. China.
Wang S; Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, Liaoning Province, 110122, P.R. China.
Sun Y; Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, Liaoning Province, 110122, P.R. China.
Wang W; Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, Liaoning Province, 110122, P.R. China.
Chang S; Department of Biomedical Engineer, School of Intelligent Medicine, China Medical University, Shenyang, Liaoning Province, 110122, P.R. China. .
Zhang Z; Department of Pancreatic and Biliary Surgery, The First Hospital of China Medical University, Shenyang, Liaoning Province, 110001, P.R. China. .
Zhao C; Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, Liaoning Province, 110122, P.R. China. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2024 Mar 27; Vol. 22 (1), pp. 194. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:
Journal Article
MeSH Terms:
Aldehyde Dehydrogenase*/genetics
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/metabolism
Humans ; Animals ; Mice ; Female ; Drug Resistance, Neoplasm ; Proto-Oncogene Proteins c-akt/metabolism ; Neoplasm Recurrence, Local/pathology ; Cell Line, Tumor ; Neoplastic Stem Cells/metabolism
Czasopismo naukowe
Tytuł:
Chronic hypoxia remodels the tumor microenvironment to support glioma stem cell growth.
Autorzy:
Nicholson JG; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Cirigliano S; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Singhania R; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Haywood C; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Shahidi Dadras M; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Yoshimura M; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Vanderbilt D; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Liechty B; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA.
Fine HA; Department of Neurology, Weill Cornell Medicine, New York, NY, USA. .
Pokaż więcej
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2024 Mar 25; Vol. 12 (1), pp. 46. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/pathology
Glioma*/pathology
Glioblastoma*/pathology
Humans ; Tumor Microenvironment ; Ligands ; Neoplastic Stem Cells/metabolism ; Hypoxia/metabolism ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling.
Autorzy:
Luo F; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Zhang M; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Sun B; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Xu C; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Yang Y; Pediatric Translational Medicine Institute, Department of Hematology & Oncology, Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, National Health Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai, 200127, China.
Zhang Y; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Li S; Pediatric Translational Medicine Institute, Department of Hematology & Oncology, Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, National Health Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai, 200127, China.
Chen G; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Chen C; Academy of Biomedical Engineering, the Third Affiliated Hospital, Kunming Medical University, Kunming, 650500, China. .
Li Y; Pediatric Translational Medicine Institute, Department of Hematology & Oncology, Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, National Health Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai, 200127, China. .
Feng H; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2024 Mar 22; Vol. 23 (1), pp. 60. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/metabolism
Animals ; Humans ; Cell Line, Tumor ; Breast/metabolism ; Signal Transduction ; Paclitaxel/pharmacology ; Disease Models, Animal ; Neoplastic Stem Cells/metabolism ; Histone-Lysine N-Methyltransferase/metabolism ; Polo-like Kinases ; Protein Serine-Threonine Kinases/metabolism ; Tumor Suppressor Proteins/metabolism
Czasopismo naukowe
Tytuł:
Low-Dose Sorafenib Promotes Cancer Stem Cell Expansion and Accelerated Tumor Progression in Soft Tissue Sarcomas.
Autorzy:
Cruz SM; Division of Surgical Oncology, Department of Surgery, University of California Davis, Sacramento, CA 95817, USA.
Iranpur KR; Division of Surgical Oncology, Department of Surgery, University of California Davis, Sacramento, CA 95817, USA.
Judge SJ; Division of Surgical Oncology, Department of Surgery, University of California Davis, Sacramento, CA 95817, USA.
Ames E; Department of Pathology, Stanford University, Stanford, CA 94305, USA.
Sturgill IR; Bioinformatics and Computational Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Farley LE; Division of Surgical Oncology, Department of Surgery, University of California Davis, Sacramento, CA 95817, USA.
Darrow MA; Department of Pathology and Laboratory Medicine, University of California Davis, Sacramento, CA 95817, USA.
Crowley JS; Division of Surgical Oncology, Department of Surgery, University of California Davis, Sacramento, CA 95817, USA.
Monjazeb AM; Department of Radiation Oncology, University of California Davis, Sacramento, CA 95817, USA.
Murphy WJ; Department of Dermatology, University of California Davis, Sacramento, CA 95817, USA.
Canter RJ; Division of Surgical Oncology, Department of Surgery, University of California Davis, Sacramento, CA 95817, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 15; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Tyrosine Kinase Inhibitors*
Sarcoma*/pathology
Humans ; Sorafenib/pharmacology ; Sorafenib/therapeutic use ; Sorafenib/metabolism ; Aldehyde Dehydrogenase/metabolism ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/metabolism ; Neoplastic Stem Cells/metabolism ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Development and clinical validation of a seven-gene signature based on tumor stem cell-related genes to predict ovarian cancer prognosis.
Autorzy:
Wang G; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Liu X; Shenyang Women's and Children's Hospital, Shenyang, China.
You Y; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Chen S; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Chang X; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Yang Q; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China. .
Pokaż więcej
Źródło:
Journal of ovarian research [J Ovarian Res] 2024 Mar 13; Vol. 17 (1), pp. 58. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/genetics
Humans ; Female ; Prognosis ; Nomograms ; Neoplastic Stem Cells
Czasopismo naukowe
Tytuł:
Regulation of cancer stem cells by CXCL1, a chemokine whose secretion is controlled by MCM2.
Autorzy:
Kahm YJ; Department of Radiation Biology, Environmental Safety Assessment Research Division, Korea Atomic Energy Research Institute, 111, Daedeok-Daero 989 Beon-Gil, Yuseong-Gu, 34057, Daejeon, Korea.; Department of Radiation Science and Technology, Korea University of Science and Technology, Yuseong-Gu, 34113, Daejeon, Korea.
Kim IG; Department of Radiation Biology, Environmental Safety Assessment Research Division, Korea Atomic Energy Research Institute, 111, Daedeok-Daero 989 Beon-Gil, Yuseong-Gu, 34057, Daejeon, Korea.; Department of Radiation Science and Technology, Korea University of Science and Technology, Yuseong-Gu, 34113, Daejeon, Korea.
Kim RK; Department of Radiation Biology, Environmental Safety Assessment Research Division, Korea Atomic Energy Research Institute, 111, Daedeok-Daero 989 Beon-Gil, Yuseong-Gu, 34057, Daejeon, Korea. .; Department of Radiation Science and Technology, Korea University of Science and Technology, Yuseong-Gu, 34113, Daejeon, Korea. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 07; Vol. 24 (1), pp. 319. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Minichromosome Maintenance Proteins*/genetics
Lung Neoplasms*
Humans ; Chemokine CXCL1 ; Proteins ; Neoplastic Stem Cells/metabolism ; Minichromosome Maintenance Complex Component 2/genetics ; Minichromosome Maintenance Complex Component 2/metabolism ; Cell Cycle Proteins/genetics ; Tumor Microenvironment
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies